This session delves into the latest advancements in transcatheter tricuspid valve interventions, covering procedural considerations, patient selection, and imaging techniques. Explore case studies, strategies for tricuspid transcatheter edge-to-edge repair, and key criteria for valve replacement. Learn about managing failed T-TEER cases and the role of transcatheter...

This session explores the diagnostic challenges and treatment strategies for mixed and multiple valvular heart diseases. Through case scenarios, including aortic stenosis, regurgitation, and combined atrioventricular valve regurgitation, learn how to use imaging modalities to assess severity and determine optimal treatment timing.

Dive into this comprehensive session on mitral valve disease, covering key aspects of diagnosis, classification, assessment, management, and patient selection for transcatheter intervention. Gain in-depth knowledge through real-world case studies and multidisciplinary team discussions, equipping you with essential skills to optimize patient care.

This session explores the challenges of managing mixed and multiple valvular heart diseases, focusing on risk stratification, treatment decisions, and transcatheter intervention timing. Experts discuss assessing and treating aortic and mitral paravalvular leaks, as well as managing mitral annular calcification, using case studies to guide optimal...

There is no doubt that the original Stent for Life initiative had a huge, positive impact on morbidity and mortality in patients with STEMI in Europe. With the global Stent – Save a Life! (SSL) initiative comes the continued spread of the mission to other regions,...

Chiara De Biase provides her take on the FAST III Trial presented by Joost Daemen at ACC.26 in New Orleans. She reviews the comparison between vFFR and FFR, highlighting key findings and their impact on revascularisation strategies.

Nicola Ryan provides her take on the RESHAPE-HF2 trial presented by Stefan Anker at the ESC Congress 2024 in London and simultaneously published in the NEJM.

The RESHAPE-HF 2 trial is a prospective randomised control trial comparing transcatheter mitral valve repair (TEER) and guideline-directed medical therapy to guideline-directed medical...

In this article, Ulrich Schäfer explores the evolving landscape of access strategies in transcatheter aortic valve implantation (TAVI). While the transfemoral approach remains the gold standard, a significant proportion of patients are not suitable due to peripheral vascular disease or anatomical constraints.
Drawing on clinical evidence and...

Kalaivani Mahadevan and Fizzah Choudry provide their take on DAPT-SHOCK-MI presented by Zuzana Motovska at ESC Congress 2025 in Madrid.

Marco Spagnolo and Daniele Giacoppo report the main results of the IVUS-ACS trial presented by Shao-Liang Chen, from the Nanjing First Hospital, Nanjing Medical University, Nanjing, in a Featured Clinical Research session at ACC.24 in Atlanta and simultaneously published in The Lancet.(1)